RxDoctor Payments Data

Carl Coffey, APRN

Nurse Practitioner · Whitley City, KYNPI 1861811093

Payments from drug & device makers

$844in general payments, 2019–2025

Across 49 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$166
  • AbbVie$137
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$88
  • Amgen$85
  • Vanda Pharmaceuticals Inc.$76
  • Lilly USA, LLC$71
  • plus $221 from 6 others

What the payments were for

  • Food & beverage$844100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$844 in reported general payments places this provider in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$2,705
Medicare patients
42
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide43$28,120
EliquisApixaban28$19,627
JanuviaSitagliptin Phosphate20$14,402
Combivent RespimatIpratropium/Albuterol Sulfate18$8,430
JanumetSitagliptin Phos/Metformin Hcl12$6,765
XareltoRivaroxaban12$6,695
Spiriva RespimatTiotropium Bromide12$5,953
Breo ElliptaFluticasone/Vilanterol12$4,227
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$3,300
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen82$1,132
Celecoxib37$961
Levothyroxine Sodium151$950
Omeprazole157$938
Boostrix TdapDiphth,pertuss(Acell),tet Vac12$827
Pantoprazole Sodium93$768

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$137$28,12043 claims
GSKBreo Ellipta$54$4,22712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Whitley City

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →